...Inc. (TSX:LOR; LRP), Toronto, Ontario Business: Cancer, Gene/Cell therapy Appointed: Georg Ludwig, managing director of ConPharm...

...CONP's Reumacon, a mixture of two benzylidenated podophyllotoxin glucosides that is under review in Sweden. Conpharm AB...

...of its Reumacon rheumatoid arthritis compound, which is a mixture of two benzylidenated podophyllotoxin glucosides. Conpharm AB...